+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biliary Stents - Global Strategic Business Report

  • PDF Icon

    Report

  • 93 Pages
  • October 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302125
The global market for Biliary Stents was estimated at US$613.6 Million in 2023 and is projected to reach US$797.8 Million by 2030, growing at a CAGR of 3.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Biliary Stents Market - Key Trends and Drivers Summarized

What Are Biliary Stents and Why Are They Used?

Biliary stents are small, tubular devices inserted into the bile duct to maintain its patency and ensure the proper flow of bile from the liver to the intestine. These stents are primarily used in the treatment of bile duct obstructions caused by conditions such as cholangiocarcinoma (bile duct cancer), pancreatic cancer, gallstones, or benign strictures due to scarring and inflammation. Obstruction in the bile duct can lead to serious complications, including jaundice, biliary cirrhosis, and life-threatening infections such as cholangitis. Biliary stents help alleviate these blockages by providing a pathway for bile drainage, reducing symptoms, and preventing complications. The stents are categorized into two major types: plastic and metal. Plastic stents are generally used for short-term management due to their tendency to occlude over time, while self-expanding metallic stents (SEMS) are preferred for longer-term solutions because they provide a larger lumen and resist clogging. Biliary stents can be placed endoscopically or percutaneously depending on the nature of the obstruction, and are considered an essential tool in both palliative care and preoperative interventions to improve patient outcomes and quality of life. With their ability to reduce symptoms and improve bile flow, biliary stents have become a cornerstone in the management of malignant and benign biliary diseases.

How Are Technological Advances Making Biliary Stents More Effective?

Recent technological advancements have significantly enhanced the efficacy, durability, and safety of biliary stents, broadening their applications and improving patient outcomes. One of the most noteworthy developments is the advent of covered self-expanding metallic stents (CSEMS), which are designed to prevent tissue ingrowth and migration, common issues with traditional metal stents. These stents are coated with biocompatible materials such as polytetrafluoroethylene (PTFE) or silicone, providing an effective barrier that minimizes tumor overgrowth and prolongs stent patency. The use of anti-migration features, such as flared ends and anchoring mechanisms, has further reduced the risk of stent displacement, a complication that can necessitate repeat interventions. Additionally, the introduction of biodegradable stents, which gradually dissolve over time, offers a promising solution for benign strictures, eliminating the need for stent removal procedures. Another major innovation is the use of drug-eluting stents, which are coated with chemotherapeutic agents or anti-proliferative drugs that release medication locally to inhibit tumor growth or scar tissue formation, thereby extending the functional life of the stent. Improvements in stent delivery systems have also played a crucial role, with newer devices allowing for more precise deployment even in tortuous anatomy. These delivery systems are now equipped with enhanced pushability, flexibility, and visibility under imaging guidance, enabling gastroenterologists and interventional radiologists to navigate complex bile duct anatomy with greater ease. Such technological advancements are not only improving the effectiveness and safety profile of biliary stents but are also expanding their role in the management of both malignant and benign biliary conditions.

How Are Shifting Treatment Paradigms and Patient Demographics Shaping the Biliary Stent Market?

The biliary stent market is being shaped by evolving treatment paradigms, an aging global population, and the increasing incidence of biliary and pancreatic diseases. As the prevalence of hepatobiliary cancers continues to rise, driven by factors such as aging populations, obesity, and alcohol-related liver diseases, the demand for effective biliary decompression solutions is growing rapidly. This has led to a shift in treatment strategies, with biliary stents playing an increasingly central role in both palliative care and curative interventions. For instance, in patients with inoperable cholangiocarcinoma or pancreatic cancer, biliary stenting is now a standard part of the management protocol, as it effectively alleviates jaundice and other symptoms, improving the patient's quality of life and facilitating chemotherapy. Furthermore, the expanding use of minimally invasive endoscopic retrograde cholangiopancreatography (ERCP) procedures has driven demand for stents that can be deployed with greater precision and fewer complications. Patient demographics are also influencing market trends, as an aging global population leads to a higher prevalence of bile duct obstructions and related complications. This demographic trend has spurred the need for more durable, long-lasting stent options that can reduce the frequency of reinterventions in elderly patients who may not be ideal candidates for repeated procedures. Moreover, there is a growing emphasis on patient-centric designs that prioritize comfort and ease of placement, as well as the development of specialized stents for pediatric and adolescent patients. This trend toward tailored solutions is further driving innovation and creating opportunities for manufacturers to differentiate their products based on clinical performance and patient outcomes.

What Factors Are Driving the Rapid Growth of the Biliary Stent Market?

The growth in the biliary stent market is driven by several factors, including the increasing prevalence of biliary diseases, technological advancements in stent design, and the rising adoption of minimally invasive procedures. The growing incidence of biliary obstructions, particularly in the context of rising hepatobiliary and pancreatic cancers, is one of the primary drivers, as biliary stents are a key palliative intervention for managing symptoms and improving the quality of life in affected patients. Technological innovations, such as the development of self-expanding metal stents (SEMS), covered stents, and biodegradable stents, are also contributing significantly to market growth by addressing common complications like stent occlusion and migration, thereby extending stent longevity and reducing the need for repeat procedures. Additionally, the trend toward minimally invasive techniques, such as ERCP and percutaneous stenting, is expanding the use of biliary stents as these procedures are associated with shorter recovery times and lower complication rates compared to traditional surgical approaches. Increased awareness and early detection of biliary diseases, coupled with a growing preference for endoscopic interventions, are further bolstering the demand for advanced stenting options. Moreover, the aging global population, which is more susceptible to conditions like cholangiocarcinoma, gallstone disease, and other biliary pathologies, is driving the need for effective and durable stenting solutions. Finally, the healthcare industry's emphasis on value-based care is prompting a shift toward stents that offer both clinical efficacy and cost-efficiency, leading to increased adoption of innovative stent technologies that improve patient outcomes while reducing the overall burden on healthcare systems. These diverse factors are transforming the biliary stent market, positioning it for sustained growth as the demand for effective biliary drainage solutions continues to rise.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Ambulatory Surgery Centers End-Use segment, which is expected to reach US$369.0 Million by 2030 with a CAGR of a 3.5%. The Hospitals End-Use segment is also set to grow at 4.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $166.0 Million in 2023, and China, forecasted to grow at an impressive 6.3% CAGR to reach $162.4 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Biliary Stents Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biliary Stents Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Biliary Stents Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Biliary Stents market such as Blue Belt Technologies, Boston Scientific Corporation, Brainlab, Claron Technology, Fiagon and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 42 companies featured in this Biliary Stents market report include:

  • Blue Belt Technologies
  • Boston Scientific Corporation
  • Brainlab
  • Claron Technology
  • Fiagon
  • GE Healthcare
  • Karl Storz
  • MAKO
  • Medacta International
  • Medtronic plc
  • Micromar
  • OrthAlign
  • Scopis
  • Stryker Corporation

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Biliary Stents - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Biliary Diseases Throws the Spotlight on Stenting Solutions
  • Increasing Adoption of Minimally Invasive Procedures Drives Demand for Biliary Stents
  • Technological Innovations in Stent Design Propel Growth with Enhanced Patency Rates
  • Here`s the Story: Expanding Geriatric Population Base Sustains Growth in Biliary Stent Adoption
  • Emergence of Metal & Bioabsorbable Stents Expands Addressable Market for Advanced Solutions
  • Here`s How Rising Incidence of Pancreatic & Liver Cancers Spurs Demand in Oncology Applications
  • Rising Awareness of Non-Surgical Treatment Options Drives Adoption in High-Risk Patient Groups
  • Shift Toward Personalized Medicine Generates Opportunities for Customized Stent Solutions
  • Growing Preference for Endoscopic Ultrasound-Guided Procedures Expands Stent Utilization
  • Innovations in Coating Materials & Drug-Eluting Technologies Create Niche Growth Potential
  • Improved Imaging Techniques for Diagnosis & Placement Accelerate Adoption in Complex Cases
  • Rising Focus on Reducing Post-Procedural Complications Spurs Innovations in Stent Engineering
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Biliary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 13: World Biliary Stents Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 14: USA Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 15: USA Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 16: USA 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
CANADA
  • Table 17: Canada Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 18: Canada Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 19: Canada 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
JAPAN
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 20: Japan Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 21: Japan Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 22: Japan 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
CHINA
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 23: China Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 24: China Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 25: China 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
EUROPE
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 26: Europe Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 27: Europe Historic Review for Biliary Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: Europe 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 29: Europe Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 30: Europe Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: Europe 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
FRANCE
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 32: France Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 33: France Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 34: France 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
GERMANY
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 35: Germany Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 36: Germany Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 37: Germany 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
ITALY
  • Table 38: Italy Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 39: Italy Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 40: Italy 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 41: UK Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 42: UK Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 43: UK 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
SPAIN
  • Table 44: Spain Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 45: Spain Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 46: Spain 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
RUSSIA
  • Table 47: Russia Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 48: Russia Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 49: Russia 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 50: Rest of Europe Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 51: Rest of Europe Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 52: Rest of Europe 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 54: Asia-Pacific Historic Review for Biliary Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 55: Asia-Pacific 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 57: Asia-Pacific Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 58: Asia-Pacific 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
AUSTRALIA
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • Table 59: Australia Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 60: Australia Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 61: Australia 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
INDIA
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • Table 62: India Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 63: India Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 64: India 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
SOUTH KOREA
  • Table 65: South Korea Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 66: South Korea Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 67: South Korea 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
  • Table 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 69: Rest of Asia-Pacific Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 70: Rest of Asia-Pacific 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
LATIN AMERICA
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
  • Table 71: Latin America Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 72: Latin America Historic Review for Biliary Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 73: Latin America 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • Table 74: Latin America Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 75: Latin America Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 76: Latin America 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
ARGENTINA
  • Table 77: Argentina Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 78: Argentina Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 79: Argentina 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
BRAZIL
  • Table 80: Brazil Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 81: Brazil Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 82: Brazil 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
MEXICO
  • Table 83: Mexico Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 84: Mexico Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 85: Mexico 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
  • Table 86: Rest of Latin America Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 87: Rest of Latin America Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 88: Rest of Latin America 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
MIDDLE EAST
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
  • Table 89: Middle East Recent Past, Current & Future Analysis for Biliary Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 90: Middle East Historic Review for Biliary Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 91: Middle East 16-Year Perspective for Biliary Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • Table 92: Middle East Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 93: Middle East Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 94: Middle East 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
IRAN
  • Table 95: Iran Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 96: Iran Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 97: Iran 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
ISRAEL
  • Table 98: Israel Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 99: Israel Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 100: Israel 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
SAUDI ARABIA
  • Table 101: Saudi Arabia Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 102: Saudi Arabia Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 103: Saudi Arabia 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
  • Table 104: UAE Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 105: UAE Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 106: UAE 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
  • Table 107: Rest of Middle East Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 108: Rest of Middle East Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 109: Rest of Middle East 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
AFRICA
  • Biliary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
  • Table 110: Africa Recent Past, Current & Future Analysis for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • Table 111: Africa Historic Review for Biliary Stents by End-Use - Ambulatory Surgery Centers, Hospitals and Specialty Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 112: Africa 16-Year Perspective for Biliary Stents by End-Use - Percentage Breakdown of Value Sales for Ambulatory Surgery Centers, Hospitals and Specialty Clinics for the Years 2014, 2024 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Blue Belt Technologies
  • Boston Scientific Corporation
  • Brainlab
  • Claron Technology
  • Fiagon
  • GE Healthcare
  • Karl Storz
  • MAKO
  • Medacta International
  • Medtronic plc
  • Micromar
  • OrthAlign
  • Scopis
  • Stryker Corporation

Table Information